Florida State Medical License
	Pennsylvania Medical License
	New York State Medical License

Board Certifications:

American Board of Internal Medicine, Internal Medicine, 2005

Education:

	BA, Degree in Biology/Sociology Columbia College, Columbia University, New York, NY 1990 - 1994
	MPH, Degree in Health Services Evaluation Universidad Autonoma de Madrid Madrid, Spain 1994 - 1995
	Postbaccalaureate Premedical Program State University of New York at Buffalo, NY 1997 - 1998
	M.D. State University of New York Downstate Medical Center, New York, NY 1998 - 2002
	Clinical Research Certificate Program Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 2006 - 2007

Postgraduate Trainning and Fellowship Appointments:

	Internship in Internal Medicine Columbia Presbyterian Hospital, NY 2002 - 2003
	Residency in Internal Medicine Columbia Presbyterian Hospital, NY 2003 - 2005
	Fellowship in Hematology-Oncology University of Pennsylvania Hospital, PA 2005 - 2008
	Chief Fellow, Hematology-Oncology Division University of Pennsylvania Hospital 2006 - 2007

Work/Research Experience:

	Program Assistant, Comprehensive Sickle Cell Program Clinic Coordinator, Multicenter Study of Hydroxyurea St. Luke’s-Roosevelt Hospital Center, New York, NY 1993 - 1994
	Research Assistant, Centro Universitario de Salud Publica Madrid, Spain 1994 - 1995
	Policy Analyst, Center for Health Affairs, Project Hope Bethesda, MD 1996 - 1997
	Research Assistant, Breast Cancer Center, King’s County Hospital Brooklyn, NY 1999 - 2001
	Research Fellow, Division of Thoracic Oncology, Hospital of the University of Pennsylvania Philadelphia, PA. Work as co-investigator in the following studies: 2006 - 2008 Phase II Study of Sorafenib in Combination with Carboplatin and Docetaxel in the First Line Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer. START Trial: Stimulating Targeted Antigenic Responses to NSCLC. A phase III study assessing the efficacy and safety of Stimuvax (BLP25 Liposome Vaccine) as a potential treatment for patients with unresectable Stage III NSCLC. A Phase 1, Open-Label, Dose-escalation, Multiple Dose Study of the Safety, Tolerability, and Immune Response of CRS-207 in Adult Subjects with Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment Discovery of Biomarkers in Advanced Non-Small Cell Lung Cancer. The goal of this project is to discover a gene expression profile that can be used in clinical practice to diagnose and monitor patients with lung cancer.

Professional Societies:

	American Society of Hematology
	American Society of Clinical Oncology
	American Association for Cancer Research
	National Hispanic Medical Association
	National Lung Cancer Partnership
	International Mesothelioma Interest Group

Honors and Awards:

	Columbia College Alumni Award for Distinguished Service, 1994
	Daniel Hale Williams Medical Society Service Award, 1999
	The Arthur Kallet/Harold Aaron Fund Scholar, National Medical Fellowship, 2000
	Jonathan L. Weiner International Health Fellowship for Health Care in Developing Countries, 2001
	Student National Medical Association, 17th Annual Dr. Wilbert C. Jordan Research Forum Award, 2001
	Distinction in Breast Cancer Research, SUNY Downstate Medical Center Graduation Award, 2002
	N.I.H. Cancer Center Research Training Grant, 2006
	N.I.H. Loan Repayment Program Award, 2007
	National Comprehensive Cancer Network (NCCN) Fellow’s Recognition Program, 2007
	ASCO/AACR Vail Methods in Clinical Research Workshop, 2007

Committees:

	Student Health Advisory Committee, SUNY Downstate Medical Center 1998 - 2000
	SUNY Downstate Medical School Admissions Committee 2001 - 2002
	Membership Chair, National Boricua/Latino Health Organization 2001 - 2002
	Columbia-Presbyterian Internal Medicine Residency Program Curriculum Development Committee 2003 - 2004
	Oncology Fellowship Admissions Committee, Hospital of the University of Pennsylvania 2006 - 2007
	Co-Coordinator, Tobacco and Enviromental Carcinogenesis: Imaging/ Clinical Trial Working Group, University of Pennsylvania 2007

Publications:

	Mark TL, Paramore LC, Rodriguez E, Good CD, Schur CL, Swalenstocker E, Neuman PJ, and Dorosh, E. The Community Impact of For-Profit Hospital Conversions: Results from Ten Case Studies, Report Commissioned by the Federation of American Health Systems, May 1997.
	Zweifler M, Rodriguez E, Reilly J, Glasberg SB, Lewis T. Factors Determining Breast Reconstruction Among Inner City Women with Breast Carcinoma. Annals of Plastic Surgery. 2001;47(1):55-59.
	Rodriguez E and Carrasquillo O. “The Role of Health Insurance on Latino Women’s Health” chapter in Latina Health: A Public Health Reader by Molina-Aguirre, Ed 2003.
	Rodriguez E. Biology and Clinical Applications of Angiogenesis in Malignant Disease. The Molecular Oncology Report, Volume 1, Number 2 (Spring 2007).
	Rodriguez E and Domchek SM. The Prevention of Hereditary Breast Cancer. Semin Oncol. 2007 Oct;34(5):401-5.
	Rodriguez E and Domchek SM. Cancer Disparities: Tumor biology and inherited breast cancer risk in African Americans. (Manuscript submitted)
	Sterman, DH, Rodriguez E and Albelda SM. Advances in the Management of Malignant Pleural Mesothelioma. Oncology Reviews (Manuscript in preparation).

Selected Presentations:

	“Socioeconomic Barriers to Health Care for Latinos”. Invited Speaker, Second Annual Conference on Latino Health: A Call to Action. New York University Medical Center, November 2, 2002.
	“The Role of Endocrine Therapy in Breast Cancer: An Update on Aromatase Inhibitors” Department of Medicine Noon Conference, Columbia-Presbyterian Medical Center, October 7, 2004.
	“Barriers to Colorectal Screening in the Primary Care Setting” Department of Medicine Quality Assurance Conference, Columbia Presbyterian Medical Center, May 9, 2005.
	“The Role of Adjuvant Therapy in Early Stage Non-Small Cell Lung Cancer.” Presented at the Hospital of the University of Pennsylvania, Cancer Education Lecture Series, March 24, 2006.
	“Management of Small Cell Lung Cancer.” Presented at the Department of Oncology Tumor Board Conference, Hospital of the University of Pennsylvania, March 19, 2007.
	“Treatment Delay and Survival among Veterans with Lung Cancer.” Philadelphia VA Medical Center, Department of Oncology Tumor Board Conference , September 21, 2007.
	“A Phase II Study of Sorafenib in Combination with Carboplatin and Docetaxel Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer.” Presented at the Hematology/Oncology Research Conference, Hospital of the University of Pennsylvania., October 29, 2007.